Impact of age, sex and body mass index on outcomes at four years after gastric banding

Obesity Surgery

Volumn 15, Issue 6, 2005, Pages 834-842

  Branson, Ruth ^b   Potoczna, Natascha ^b   Brunotte, Ricarda ^b   Piec, Grazyna ^b   Ricklin, Thomas ^b   Steffen, Rudolf ^b   Horber, Fritz F ^a  

^a Stiftung für Adipositas und Osteoporose Forschung   (Switzerland)

^b NONE

Author keywords

Adjustable gastric banding; Age; Body weight; Laparoscopy; Morbid obesity; Sex

Indexed keywords

ADULT; AGE; ARTICLE; BARIATRIC ANALYSIS AND REPORTING OUTCOME SYSTEM SCORE; BODY MASS; CONTROLLED STUDY; FEMALE; GASTRIC BANDING; GENDER; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; COMORBIDITY; FEMALE; GASTROPLASTY; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; REOPERATION; SEX FACTORS; TREATMENT OUTCOME;

EID: 21344449276     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892054222605     Document Type: Article

References (21)

1. Flegal KM, Carroll MD, Odgen CL et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-7.
2. Bender R, Jickel KH, Traunter C et al. Effect of age on excess mortality in obesity. JAMA 1999; 281: 1498-504.
3. Sjöström L, Rissanen A, Andersen T et al. Randomized placebo controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998; 352: 167-72.
4. James WPT, Astrup A, Finer N et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Lancet 2000; 356: 2119-27.
5. Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology 2002; 123: 882-932.
6. Hauri P, Steffen R, Ricklin T et al. Treatment of morbid obesity with the Swedish Adjustable Gastric Band (SAGB): complication rate during a 12-month follow-up period. Surgery 2000; 127: 484-8.
7. Oria HE, Moorehead MK. Bariatric Analysis and Reporting Outcome System (BAROS). Obes Surg 1998; 8: 487-99.
8. Gastrointestinal surgery for severe obesity 25-27 March. National Institutes of Health Consensus Development Conference Draft Statement. Obes Surg 1991; 1: 257-66.
9. Biertho L, Steffen R, Branson R et al. Management of failed adjustable gastric banding. Surgery 2005; 137: 33-41.
10. Kuzmak LI. Gastric banding. In: Deitel M, ed. Surgery for the Morbidly Obese Patient. Toronto: FD-Communications Inc 1989: 225-9.
11. Baldinger R, Münch R, Steffen R et al. Conservative management of intragastric migration of Swedish adjustable gastric band by endoscopic retrieval. Gastrointest Endosc 2001; 53: 98-101.
12. Steffen R, Biertho L, Ricklin T et al. Laparoscopic Swedish adjustable gastric banding: a five-year prospective study. Obes Surg 2003; 13: 404-11.
13. Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005; 15: 462-73.
14. Sugerman HJ, Kellum JM, Engle KM et al. Gastric bypass for treating severe obesity. Am J Clin Nutr 1992; 55: 560S-566S.
15. Chapman AE, Kiroff G, Game P et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004; 135: 326-51.
16. Kral JG, Buckley MC, Kissileff HR et al. Metabolic correlates of eating behavior in severe obesity. Int J Obes 2001; 25: 258-64.
17. Sugerman H, Windsor A, Bessos M et al. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med 1997; 241: 71-9.
18. Lemieux S, Prud'homme D, Bouchard C et al. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993; 58: 463-7.
19. Fisher BL, Pennathur A, Mutnick JL et al. Obesity correlates with gastroesophageal reflux. Dig Dis Sci 1999; 44: 2290-4.
20. Murray L, Johnston B, Lane A et al. Relationship between body mass and gastro-esophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol 2003; 32: 645-50.
21. Torgerson JS, Hauptman J, Boldrin MN et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study, a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-61.